New pain block may cut opioid use after hernia surgery

NCT ID NCT05177991

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a longer-lasting pain blocker (Exparel) works better than the standard one (Marcaine) for pain control after hernia repair. About 200 adults having minimally invasive hernia surgery will receive one of the two drugs via a nerve block before surgery. Researchers will track pain scores and how many opioid pills patients need afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Liposomal Bupivacaine (Exparel) and Bupivacaine (Marcaine)
What this could lead to
If Exparel works better, patients could have less pain and need fewer opioid pills after hernia surgery.
What could go wrong
This is a very early, small trial, so results may not be conclusive or apply to all hernia patients. Both drugs are already used, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INGUINAL HERNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hernia, Inguinal Hernia, Ventral

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karl LeBlanc

    Baton Rouge, Louisiana, 70808, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.